五元杂环并嘧啶类MTH1抑制剂的设计、合成及生物活性评价  

Design,synthesis and biological evaluation of five-membered heterocyclopyrimidines as MTH1 inhibitors

作　　者：王蕾 马俊 顾梦月 狄蓉蓉 刘煜[2] 赖宜生[1] WANG Lei;MA Jun;GU Mengyue;DI Rongrong;LIU Yu;LAI Yisheng(Center of Drug Discovery,China Pharmaceutical University,Nanjing 210009,China;School of Life Science and Technology,China Pharmaceutical University,Nanjing 210009,China)

机构地区：[1]中国药科大学新药研究中心,南京210009 [2]中国药科大学生命科学与技术学院,南京210009

出　　处：《中国药科大学学报》2018年第4期407-412,共6页Journal of China Pharmaceutical University

基　　金：国家自然科学基金资助项目(No.21472244)~~

摘　　要：在MTH1抑制剂TH287的基础上,采用闭环、骨架跃迁和生物电子等排等药物设计策略,结合计算机辅助药物设计方法,设计并合成了17个五元杂环并嘧啶类目标化合物(I_(1~10),II_(1~7))。采用孔雀石绿显色法评价了目标化合物对MTH1酶活性的影响,结果表明该类化合物具有良好的MTH1抑制活性,其中7个化合物的(I_3,I_4,I_(7~9))IC_(50)低于1μmol/L,可以作为新型MTH1抑制剂开展进一步的研究。Based on the reported inhibitors TH287,17 five-membered heterocyclopyrimidine derivatives were designed and synthesized by cyclization,scaffold hopping,bioisosterism and molecular docking technology.The bioassays determined by malachite green method demonstrated that the target compounds displayed good inhibitory activity against MTH1.Among them,the IC 50 value of 7 compounds was less than 1μmol/L,suggesting that these compounds may be candidates for further investigation.

关 键 词：五元杂环并嘧啶类 DNA氧化损伤 DNA修复 MTH1抑制剂 合成 抗肿瘤 生物活性评价 

分 类 号：R914[医药卫生—药物化学] R965[医药卫生—药学]